Psychedelic News

Recent analysis cites positive results of clinical psychedelic trials, coupled with a large amount of capital investment into biotech companies.

PSIL is the third psychedelics ETF to hit the markets after the launch of the world’s first psychedelic ETF earlier this year.

David Flores, CEO of Global Trac Solutions (PSYC), joins Cheddar to discuss the company's digital media platform 'Psychedelic Spotlight', factors contributing to a more open-minded approach to psychedelics among the scientific and medical…

In this episode of the Psychedelic Spotlight podcast, we speak with Joshua White, the Co-Founder and Director of Fireside Project, the first Psychedelic Peer Support Line. Joshua speaks about the creation of the Fireside Project and the future…

In this episode of the Psychedelic Spotlight podcast, we speak with David Champion who is the Co-Founder and CEO of Maya Health, a company dedicated to empowering psychedelic practitioners with the technology and insight they need to scale…

In this episode of the Psychedelic Spotlight podcast, we feature Anthony Tennyson, CEO of Awakn Life Sciences, a biotechnology company with clinical operations developing and delivering psychedelic medicine to treat addiction. In our conversation…

Podcaster and author of "The 4-Hour Work Week" will gift the university's Center for the Science of Psychedelics $800,000 over 3 years to fund fellowship overseen by Professor Pollan.

The proposal asks voters if the city should "decriminalize to the fullest extent permitted under Michigan law the personal possession and therapeutic use of entheogenic plants by adults."

In Brazil, there have been no instances of an individual being punished for the consumption, cultivation, or possession of magic mushrooms.

As the new industry blooms, researchers and other professionals are fighting to break down barriers to participation, information, and psychedelics themselves.

Michelle opens up about how her work as a cannabis writer led her down the path of psychedelics, her interest in safe magic mushroom use and why she was compelled to write her guidebook Your Psilocybin Mushroom Companion.

Steven Huang, a consultant for leading psychedelic medicine company Numinus, explains why the industry should "harness the power of diversity."

In its proposed revised 2021 quotas, the DEA suggests 4900% increase in the allowed quantities of psilocybin for research and clinical trial purposes.

Steven's consultancy company, Millennial HR Design, focuses on the intersection of DEI and psychedelics, where he intends to be a leverage point for the psychedelics industry to better understand their impact on marginalized communities. With nearly 10 years of industry experience, Steven hopes for more diverse and equitable representation in the psychedelic space. 

Did early humans accelerate evolution by tripping balls on psychedelic mushrooms? One psychonaut ethnobiologist says: absolutely.

SB 519 would decriminalize the personal use of psilocybin, psilocyn, MDMA, LSD, DMT, mescaline (excluding peyote), and ibogaine, including in group counseling and community-based healing settings.

This isn't the first time the hit songwriter has turned to psychedelics for therapy, either.

Although the trend is hot, it's still largely illegal, so consider incorporating these three stress relievers into your life. They're free, effective, and legal.

Study authors write, "Results showed significant and large reductions in the intensity of traumatic stress, depression, and anxiety symptoms from the 30 days before to the 30 days after a referent psychedelic experience."

This week in psychedelic business news: More psychedelic clinical trials are green-lighted, new partnerships inked, and Beckley Psytech successfully completes upsized Series B financing. 

Recent ayahuasca study concludes mixed messages in attempt to determine if the ancient plant medicine has power to change personality, as psilocybin has shown.

"A mushroom is not a pharmaceutical product," CEO Evan Levine stresses, and explains why his company's method of biologically engineering psilocybin is "cheaper, faster, greener."

The company will use proceeds of the fundraising round to complete its ongoing Phase 1B trial on low-dose psilocybin in patients suffering from a rare headache condition with no approved medications to treat it.

The Psychedelic Spotlight podcast guest also addresses criticism that she is a white woman working with sacred plant medicine, and how that inspired her next non-profit venture.

Nova Mentis says that psilocybin could be a novel, first-in-class treatment for a brain disorder that leads to learning disabilities and behavioral problems.

The clinics provide high-dose ketamine infusions, as well as intramuscular ketamine infusions for group therapy.

Now streaming on Netflix, this critically acclaimed film gives viewers a glimpse into a clinical psilocybin trip while revealing that mushrooms have so much more to offer humanity.

We compare two polls of roughly the same sample size in two neighboring countries, and find a stark difference in attitudes.

CEO Christopher Dawson and COO Andrew Galloway spent years working in clinical mental health treatment centers before betting big on psychedelics and ancient healing methods.

"This designation not only expedites our regulatory, clinical, and product development plans but also validates our belief in the potential of ketamine," says PharmaTher CEO Fabio Chianelli.

As a result, the Canadian Psychedelic Association responds with a Memorandum of Regulatory Approval, which advises medicinal psilocybin therapy to be authorized in a safe and therapeutic environment.

City Commissioner Kurt Reppart believes there is enough support to pass a resolution as early as fall.

This week in psychedelic business news: More psychedelic-assisted therapy clinics, recruitment begins in early DMT trial, and Filament gets more Health Canada love.

Republican Tracy Pennycuick and Democrat Jennifer O’Mara are the latest politicians to take notice of the proven therapeutic use of psilocybin.

The global supply chain of regulated psilocybin and ibogaine continues to grow as these Canadian companies beef up manufacturing efforts.

In this episode of the Psychedelic Spotlight podcast, we feature James Hallifax, Co-Founder of The Psychedelic Investor.

And in other psychedelic stock news, Origin Therapeutics launches to make equity investments in emerging psychedelics-related companies.

Fungi bioscience company describes the project as “one of the most robust genetics research initiatives in the emerging psychedelics space to date."

Medavie Blue Cross partners with medical research company Braxia Scientific to cover ketamine care for veterans at Canadian Rapid Treatment Centres of Excellence.

And why the two-time Stanley Cup champion does not imagine working with the NHL in the "near future."

The PsycheDev app guides users through intention setting, meditation, learning, contemplation and questioning, serving as a virtual facilitator and integration coach.

In this episode of the Psychedelic Spotlight podcast we catch up with Daniel Carcillo, Founder and CEO of Wesana Health.

The actress is the latest celebrity to give ayahuasca a shot, following in the footsteps of Miley Cyrus and Chelsea Handler.

We speak with Anthony Tennyson, CEO of Awakn Life Sciences, a biotechnology company with clinical operations developing and delivering psychedelic medicine to treat addiction.

This week in psychedelic business news: It’s all about partnerships and acquisitions designed to advance psychedelic therapies for depression, suicidal ideation, pain, and more.

Decriminalization is one step behind legalization. Selling entheogenic plants or fungi remains a felony that could warrant prison time.

NCT will utilize Numinus' expertise in psychedelic-assisted therapy to create a specialization in the application of psychedelics in the field of neurology

This week in psychedelic business news: Companies embrace the psychedelic aspects of VR, Braxia trains therapists in psychedelic best practices, and Allied gears up to provide its psychedelic formulation to PTSD patients.

As psychedelic medicine gains momentum, a growing number of organizations are offering psychedelic facilitator programs. Here's how to become one.

In this episode of the Psychedelic Spotlight podcast we speak with Lauren Taus who is the Founder of INBodied Life, who's focus is on integrating modern science and ancient wisdom to support transformation.

Ontario’s Queen’s University’s is launching a psychedelics research collaborative to serve as a space for innovation, and education.

Psychedelic life sciences company Wesana Health has partnered with the University of South Carolina to study brain health.

Former Food and Drug Administration division director Dr. Thomas Laughren has joined the psychedelic life sciences team at Cybin.

A new platform is aimed at psychedelic experience integration and harm reduction by surveying practitioners and patients.

A shop in Berlin run by a man who claims to be related to former U.S. President Donald Trump, is legally selling an LSD analog.

Texas Gov. Greg Abbott signed a bill requiring the state to study the risks and benefits of psychedelics for veterans suffering with PTSD.

This week in psychedelic business news: Patent progress for biosynthetic psilocybin, psychedelics for brain health, and psychedelic and cannabis companies team up in the name of research.

Will taking psychedelics turn you into a liberal hippie? Here's everything you need to know about psychedelics and political beliefs.

Representatives Cori Bush and Bonnie Watson Coleman have introduced legislation to end the federal war on drugs once and for all.

New research into psychedelics shows psilocybin may help amputees suffering from pain associated with phantom limb syndrome.

This week in psychedelic business news: An all-female biotech company, psychedelic-assisted psychotherapy for COVID front-liners, and more.

A new investigation into treatment for migraines spotlights the psychedelic psilocybin mushroom as a promising prospect.